IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 109

Article Submitted : 16043

Article Published : 7066

Total Authors : 19003

Total Reviewer : 686

Total Countries : 125

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Cost Minimization Analysis of Conventional and Newer Anti diabetics in India
Authors Name: Dr.S.Archana , Dr.G.Jayashree
Download E-Certificate: Download
Author Reg. ID:
IJRTI_183211
Published Paper Id: IJRTI2207179
Published In: Volume 7 Issue 7, July-2022
DOI:
Abstract: The aim of this paper is to assess the cost difference of various branded and generic oral antidiabetic drugs available in the Indian market. There are innumerable brands of oral anti-diabetic drugs present in the market with a wide variation in the cost of various branded and generic anti-diabetics. The consideration of cost of treatment is one of the important aspects in health economics. Hence this study was done to assess the cost variation of various preparations of anti-diabetics (branded and generic) available in India. The maximum and minimum price of each oral antidiabetic drug in rupees (INR) was noted by using “Current Index of Medical Specialties” (CIMS) July October 2020, Drug Today July-October 2020 and www.1mg.com. The cost ratio and the percentage of cost variation for individual drugs was calculated and compared.
Keywords: Antidiabetics, Cost minimization analysis, Cost ratio, Pharmacoeconomics, Percentage of cost variation
Cite Article: "Cost Minimization Analysis of Conventional and Newer Anti diabetics in India", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 7, page no.1122 - 1145, July-2022, Available :http://www.ijrti.org/papers/IJRTI2207179.pdf
Downloads: 000204856
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2207179
Registration ID:183211
Published In: Volume 7 Issue 7, July-2022
DOI (Digital Object Identifier):
Page No: 1122 - 1145
Country: Chennai, Tamil Nadu, India
Research Area: Medical Science
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2207179
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2207179
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner